INTEgRated Health CARE for Patients With Frailty and Heart Failure
Launched by VESTRE VIKEN HOSPITAL TRUST · May 30, 2024
Trial Information
Current as of February 14, 2025
Recruiting
Keywords
ClinConnect Summary
The INTEgRated Health CARE for Patients With Frailty and Heart Failure (INTERCARE-HF) trial is studying a new approach to help elderly patients who have both heart failure and severe frailty. Frailty means being more vulnerable to health problems, which can make managing heart failure more complicated. This trial aims to see if coordinated care from a team of healthcare professionals can improve these patients' quality of life, reduce their symptoms, and ease the stress on their caregivers. The study will involve about 20 patients with heart failure and a specific level of frailty, and they will be compared to a control group of 40 matched patients.
To be eligible, participants need to be over 18 years old, currently in the hospital for heart failure symptoms, and have a certain level of frailty. They will need to sign consent forms and agree to work together with the healthcare team. Throughout the trial, participants can expect personalized care plans tailored to their needs, regular follow-ups, and support in managing their health. This trial is currently recruiting participants, and the results will help shape better care strategies for elderly patients with heart failure in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years old
- • Admitted to hospital with heart failure with symptoms of decompensation including dyspnoea in NYHA class ≥ II, pulmonary congestion on chest x-ray and/or other signs like oedema or positive rales on auscultation and elevated NT-proBNP concentrations at screening
- • Clinical Frailty Score ≥5
- • Signed informed consent by patient and closest relatives\* and expected cooperation according to the protocol, ICH/GCP and national/local regulations
- • Although we preferably will recruit both patients and their relatives, participation from the next-of-kin will not be an exclusion criterium.
- Exclusion Criteria:
- • Inability to comply with all study requirements, due to major co-morbidities or psychosocial issues, or a history of noncompliance, that might compromise the patient's ability to understand and/or comply with the protocol instructions or follow-up procedures.
- • Not being able to understand Norwegian.
- • Permanent nursing home and estimated to stay alive for less than 6 months
About Vestre Viken Hospital Trust
Vestre Viken Hospital Trust is a prominent healthcare institution in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a leading sponsor of clinical trials, Vestre Viken focuses on innovative healthcare solutions that enhance patient outcomes and contribute to scientific knowledge. The trust collaborates with various stakeholders, including academic institutions and industry partners, to facilitate rigorous research initiatives across multiple therapeutic areas. Committed to ethical standards and patient safety, Vestre Viken aims to foster an environment that promotes cutting-edge medical advancements and improves healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Drammen, , Norway
Drammen, Viken, Norway
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0